QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG
Venlo (pta031/03.02.2026/22:05 UTC+1) - Release of Voting Rights Announcement
The AFM (the Netherlands Authority For the Financial Markets) has informed us on February 3, 2026 that a notification related to our institution has been released by the AFM.
The following notification has been disclosed in the relevant register on the AFM website:
Date of transaction: 28 Jan 2026
Person obliged to notify: Goldman Sachs Group Inc., The
Issuing institution: Qiagen N.V.
Registration Chamber of Commerce: 12036979
Place of residence: VENLO
Distribution in numbers
| Type of share | Number of shares | Number of voting rights | Capital interest | Voting rights | Manner of disposal | Settlement |
| Ordinary share | 13.423,00 | 13.423,00 | Potential | Potential | Middellijk (Goldman Sachs Bank Europe SE) | Physical delivery |
| Ordinary share | 17,00 | 17,00 | Real | Real | Middellijk (Folio Investments, Inc.) | Physical delivery |
| Convertible bond | 879.852,00 | 879.852,00 | Potential | Potential | Middellijk (Goldman Sachs International) | Physical delivery |
| Ordinary share | 473.914,00 | 473.914,00 | Potential | Potential | Middellijk (Goldman Sachs & Co. LLC) | Physical delivery |
| Ordinary share | 1.519.574,00 | 1.519.574,00 | Potential | Potential | Middellijk (Goldman Sachs International) | Physical delivery |
| Swap | 681.614,00 | 681.614,00 | Potential | Potential | Middellijk (Goldman Sachs & Co. LLC) | In cash |
| Warrant | 49.212,00 | 49.212,00 | Potential | Potential | Middellijk (Goldman Sachs Bank Europe SE) | In cash |
| Swap | 510.042,00 | 510.042,00 | Potential | Potential | Middellijk (Goldman Sachs Bank USA) | In cash |
| Ordinary share | 160.835,00 | 160.835,00 | Real | Real | Middellijk (Goldman Sachs International) | Physical delivery |
| Ordinary share | 17.220,00 | 17.220,00 | Real | Real | Middellijk (Goldman Sachs Bank Europe SE) | Physical delivery |
| Call-option | 871.200,00 | 871.200,00 | Potential | Potential | Middellijk (Goldman Sachs International) | Physical delivery |
| Convertible bond | 108.646,00 | 108.646,00 | Potential | Potential | Middellijk (Goldman Sachs & Co. LLC) | Physical delivery |
| Ordinary share | 13.150,00 | 13.150,00 | Real | Real | Middellijk (The Goldman Sachs Trust Company of Delaware) | Physical delivery |
| Swap | 1.140.759,00 | 1.140.759,00 | Potential | Potential | Middellijk (Goldman Sachs International) | In cash |
Distribution in percentages
| Type | Total holding | Directly real | Directly potential | Indirectly real | Indirectly potential |
| Capital interest | 3,11 % | 0,00 % | 0,00 % | 0,09 % | 3,02 % |
| Voting rights | 3,11 % | 0,00 % | 0,00 % | 0,09 % | 3,02 % |
QIAGEN N.V. is not responsible for the accuracy and correctness of the notification above. The content has been taken from the relevant register of the AFM: https://www.afm.nl/sector/registers/meldingenregisters/substantiele-deelnemingen/details?id=187068
(end)
| Emitter: |
QIAGEN N.V. Hulsterweg 82 5912 PL Venlo Netherlands |
|
|---|---|---|
| Contact Person: | Investor Relations | |
| Phone: | +31 7735566 - 00 | |
| E-Mail: | ir@qiagen.com | |
| Website: | www.qiagen.com | |
| ISIN(s): | NL0015002SN0 (Share) | |
| Stock Exchange(s): | Regulated Market in Frankfurt; Free Market in Dusseldorf, Hamburg, Hannover, Munich, Stuttgart, Tradegate BSX | |
| Other Stock Exchanges: | NYSE, SIX, BX Swiss |